Publications Categories All categoriesNewslettersPodcastsNews ReleaseOpinionPosition & Policy PapersReportsStatementsConsultation Responses Topic Topic TopicAll Topics2024 EU ElectionsAccess to MedicinesAgriculture & FoodAlcoholAntimicrobial Resistance (AMR)CancerChild HealthClean Air, Transport & CitiesClean Cooking & HeatingClimate CrisisDigital HealthDiscriminationEPHA NewsEurope and HealthHealth WorkforceHuman RightsMental HealthNon Communicable Diseases (NCDs)ObesityPandemics & Infectious DiseasesPartnershipsRoma HealthSocial Determinants of HealthSustainabilityTobaccoTrade & HealthUniversal Health Coverage Policy Policy PolicyAll PoliciesHealthy EnvironmentsHealthcare DeliveryHealth EquityHealth Systems and EconomyGlobal Public HealthDigital TransformationPolitics and Health Search Search Search Clear March 5, 2024Extended periods of data protection are not the best solution for either health budgets or access to medicines for allThe patients, healthcare users, and public health organisations we represent are extremely concerned about the...StatementsHealthcare DeliveryAccess to MedicinesDecember 5, 2023Health Equity Feed | Mental health of refugees and migrants, housing accessibility for Roma, and moreEPHA’s Health Equity Feed brings you the latest news, events, and research on health equity...NewslettersHealth EquityHealthcare DeliveryMental HealthRoma HealthSeptember 29, 2023EPHA’s Recommendations for the European Pharmaceutical PackageIn this short paper, we provide targeted recommendations to the current proposal on issues related...Position & Policy PapersHealthcare DeliveryAccess to MedicinesAugust 31, 2023Why you should care about Substances of Human Origin (SoHO)?In a world and time when health and healthcare are mainly approached from a commercial...OpinionHealth Systems and EconomyHealthcare DeliveryAccess to MedicinesJune 26, 2023Improving the transparency of clinical trials in the EUOn 22 and 23 June 2023, EPHA attended the kick-off workshop of the multistakeholder platform...ReportsHealthcare DeliveryEurope and HealthJune 1, 2023EPHA Newsletter | Exploring elements of the EU’s pharmaceutical legislationDeveloped in 1965, the first EU pharmaceutical legislation was a response to the tragic consequences...NewslettersHealthcare DeliveryAccess to MedicinesMay 31, 2023Will transparency of R&D costs lead to more affordable medicines?Without clear knowledge of pharmaceutical R&D costs, it is virtually impossible for regulators to design...OpinionHealthcare DeliveryAccess to MedicinesMay 31, 2023What could change in the fight against medicine shortages in Europe?With the COVID-19 pandemic and the multiplication of antibiotic supply disruptions, the fight against medicine...OpinionHealthcare DeliveryAccess to MedicinesMay 31, 2023Academic development of medicines – a path to solving unmet medical needsBy Dr Ward Rommel, Chair, Access to Medicines Task Force of Association of European Cancer...OpinionHealthcare DeliveryAccess to MedicinesApril 26, 2023Revising the EU pharmaceutical legislation and putting People before (Pharma) ProfitsEPHA welcomes the European Commission’s proposal and calls for a balanced debate so that the...News ReleaseHealthcare DeliveryPolitics and HealthAccess to MedicinesApril 12, 2023Why should one care about the new EU pharma law?Have you ever been to the pharmacy and couldn’t find the medicine you were looking...PodcastsHealthcare DeliveryPolitics and HealthAccess to MedicinesMarch 29, 2023Letter to Commission President on the delayed publication of the EU pharmaceutical legislation revisionThis new postponement is jeopardising the adoption of a balanced, fair, and robust pharmaceutical framework...StatementsHealthcare DeliveryAccess to MedicinesEurope and HealthMarch 9, 2023CSOs call on the European Commission to publish revised EU pharmaceutical legislation no later than in March 2023Brussels, 9 March 2023 Dear Commissioner Kyriakides, We, the signatory organisations representing civil society, patients,...StatementsHealthcare DeliveryAccess to MedicinesMarch 7, 2023EPF and EPHA met with Commissioners Schinas and Kyriakides to discuss the ongoing pharmaceutical legislation revision and medicine shortagesBrussels, 7 March 2023 Yesterday afternoon, the European Public Health Alliance (EPHA) and the European...News ReleaseHealthcare DeliveryAccess to MedicinesFebruary 28, 2023EPHA’s contribution to the WHO Europe Access to Novel Medicines PlatformEPHA participated in an online consultation and submitted comments to the WHO Europe on their...Consultation ResponsesHealthcare DeliveryAccess to MedicinesFebruary 10, 2023Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationThe transferable exclusivity voucher is a costly, complex and untested incentive for new antibiotics. It...Position & Policy PapersHealthcare DeliveryAccess to MedicinesJanuary 25, 2023Joint letter | The shortage of antibiotics should be considered a “major event”To the EMA Executive DirectorTo the members of the Executive Steering Group on Shortages and...StatementsHealthcare DeliveryAccess to MedicinesJanuary 11, 2023Untapped Potential: Integrating Patient Perspectives for Inclusive Health Care Decision-MakingOECD’s Patient-Reported Indicator Surveys (PaRIS) initiative aims to measure outcomes and experiences of healthcare as...Position & Policy PapersHealthcare DeliveryPolitics and Health Load more Get the EPHA Newsletter SUBSCRIBE
March 5, 2024Extended periods of data protection are not the best solution for either health budgets or access to medicines for allThe patients, healthcare users, and public health organisations we represent are extremely concerned about the...StatementsHealthcare DeliveryAccess to Medicines
December 5, 2023Health Equity Feed | Mental health of refugees and migrants, housing accessibility for Roma, and moreEPHA’s Health Equity Feed brings you the latest news, events, and research on health equity...NewslettersHealth EquityHealthcare DeliveryMental HealthRoma Health
September 29, 2023EPHA’s Recommendations for the European Pharmaceutical PackageIn this short paper, we provide targeted recommendations to the current proposal on issues related...Position & Policy PapersHealthcare DeliveryAccess to Medicines
August 31, 2023Why you should care about Substances of Human Origin (SoHO)?In a world and time when health and healthcare are mainly approached from a commercial...OpinionHealth Systems and EconomyHealthcare DeliveryAccess to Medicines
June 26, 2023Improving the transparency of clinical trials in the EUOn 22 and 23 June 2023, EPHA attended the kick-off workshop of the multistakeholder platform...ReportsHealthcare DeliveryEurope and Health
June 1, 2023EPHA Newsletter | Exploring elements of the EU’s pharmaceutical legislationDeveloped in 1965, the first EU pharmaceutical legislation was a response to the tragic consequences...NewslettersHealthcare DeliveryAccess to Medicines
May 31, 2023Will transparency of R&D costs lead to more affordable medicines?Without clear knowledge of pharmaceutical R&D costs, it is virtually impossible for regulators to design...OpinionHealthcare DeliveryAccess to Medicines
May 31, 2023What could change in the fight against medicine shortages in Europe?With the COVID-19 pandemic and the multiplication of antibiotic supply disruptions, the fight against medicine...OpinionHealthcare DeliveryAccess to Medicines
May 31, 2023Academic development of medicines – a path to solving unmet medical needsBy Dr Ward Rommel, Chair, Access to Medicines Task Force of Association of European Cancer...OpinionHealthcare DeliveryAccess to Medicines
April 26, 2023Revising the EU pharmaceutical legislation and putting People before (Pharma) ProfitsEPHA welcomes the European Commission’s proposal and calls for a balanced debate so that the...News ReleaseHealthcare DeliveryPolitics and HealthAccess to Medicines
April 12, 2023Why should one care about the new EU pharma law?Have you ever been to the pharmacy and couldn’t find the medicine you were looking...PodcastsHealthcare DeliveryPolitics and HealthAccess to Medicines
March 29, 2023Letter to Commission President on the delayed publication of the EU pharmaceutical legislation revisionThis new postponement is jeopardising the adoption of a balanced, fair, and robust pharmaceutical framework...StatementsHealthcare DeliveryAccess to MedicinesEurope and Health
March 9, 2023CSOs call on the European Commission to publish revised EU pharmaceutical legislation no later than in March 2023Brussels, 9 March 2023 Dear Commissioner Kyriakides, We, the signatory organisations representing civil society, patients,...StatementsHealthcare DeliveryAccess to Medicines
March 7, 2023EPF and EPHA met with Commissioners Schinas and Kyriakides to discuss the ongoing pharmaceutical legislation revision and medicine shortagesBrussels, 7 March 2023 Yesterday afternoon, the European Public Health Alliance (EPHA) and the European...News ReleaseHealthcare DeliveryAccess to Medicines
February 28, 2023EPHA’s contribution to the WHO Europe Access to Novel Medicines PlatformEPHA participated in an online consultation and submitted comments to the WHO Europe on their...Consultation ResponsesHealthcare DeliveryAccess to Medicines
February 10, 2023Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationThe transferable exclusivity voucher is a costly, complex and untested incentive for new antibiotics. It...Position & Policy PapersHealthcare DeliveryAccess to Medicines
January 25, 2023Joint letter | The shortage of antibiotics should be considered a “major event”To the EMA Executive DirectorTo the members of the Executive Steering Group on Shortages and...StatementsHealthcare DeliveryAccess to Medicines
January 11, 2023Untapped Potential: Integrating Patient Perspectives for Inclusive Health Care Decision-MakingOECD’s Patient-Reported Indicator Surveys (PaRIS) initiative aims to measure outcomes and experiences of healthcare as...Position & Policy PapersHealthcare DeliveryPolitics and Health
